The North America Veterinary Diagnostics Market would witness market growth of 9.3% CAGR during the forecast period (2023-2030).
Veterinary diagnostic laboratories and services offer testing, interpretation, and consultation services to veterinarians and animal owners. These services include clinical pathology, microbiology, histopathology, and more. The market serves companion animals (pets) and livestock (farm animals). Different tests and services are used for these two segments, with a growing focus on food safety and disease control in livestock.
The increasing number of pets has driven the demand as pet owners seek to provide the best care for their animals. Disease outbreaks in livestock, such as avian influenza or bovine tuberculosis, highlight the need for efficient and accurate diagnostic tools to control the spread of diseases and ensure food safety. Advances in diagnostic technologies, including molecular biology techniques and automation, have improved the speed and accuracy of veterinary diagnostics. Regulations and guidelines governing animal health and safety, such as disease surveillance and prevention, impact the market.
The North American market has been experiencing steady growth due to various factors, such as increasing pet ownership, rising awareness about animal health, and advancements in diagnostic technologies. Adopting veterinary diagnostics for companion animals (dogs, cats, etc.) has been particularly strong. Pet owners are increasingly inclined to invest in their pets' health, leading to a higher demand for diagnostic services. The estimated number of households owning pet birds, cats, dogs, horses, freshwater fishes, saltwater fishes, reptiles, and other small animals are 6.1 million, 46.5 million, 65.1 million, 2.2 million, 11.1 million, 2.2 million, 6.0 million, and 6.7 million respectively. With the growing pet ownership in this region, the market is foreseen to expand.
The US market dominated the North America Veterinary Diagnostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,466 million by 2030. The Canada market is anticipated to grow at a CAGR of 11.7% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.8% during (2023 - 2030).
Based on Product, the market is segmented into Consumables, Reagents & Kits, Instruments & Devices. Based on End Use, the market is segmented into Laboratories, Veterinary Hospitals & Clinics, Point-Of-Care/In-House Testing, Research Institutes & Universities. Based on Disease Type, the market is segmented into Non-Infectious Diseases, General Ailments, Infectious Diseases, Hereditary, Congenital & Acquired Diseases, and Others. Based on Testing Type, the market is segmented into Pathology, Bacteriology & Molecular Diagnostics, Diagnostic Imaging, Immunoassays, Parasitology, Serology & Virology and Analytical Services. Based on Species, the market is segmented into Canine, Avian, Ovine, Equine, Cattle, Caprine, Feline, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Veterinary Diagnostics Market is Projected to reach USD 15.6 Billion by 2030, at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Heska Corporation (Antech Diagnostics, Inc), IDEXX Laboratories Inc., Agrolabo S.p.A., Innovative Diagnostics SAS (Idvet), Virbac, Thermo Fisher Scientific, Inc., Neogen Corporation, Covetrus, Inc. (Clayton, Dubilier & Rice, LLC), and iM3 Pty Ltd
By Product
By End Use
By Disease Type
By Testing Type
By Species
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 